Screens for/monitors diabetes; reflects average blood glucose over 2-3 months.
Simple, reproducible, indicator of kidney filtration.
Biomarker for systemic inflammation in CV risk assessment.
Sensitive marker of hepatobiliary dysfunction and oxidative stress.
Screens for dyslipidemia; assesses CV risk via cholesterol levels. (TC, LDL, HDL)
Screens for megaloblastic anemia and GLP-1 related nutritional deficiencies.
Lp(a) The 2026 ACC/AHA Dyslipidemia Guideline recommends measurement of Lp(a) concentration at least once in all adults for ASCVD risk assessment